
<!DOCTYPE HTML>
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, user-scalable=no, initial-scale=1, maximum-scale=1" />
    <title>Beyond Air Accelerates LungFit™ BRO COVID-19 Program Nasdaq:XAIR</title>
    <link rel="shortcut icon" href="/Content/Images/favicon.ico" type="image/x-icon" />

    <link rel="stylesheet" type="text/css" href="/Content/css/fontawesome-all.min.css" />
    <link href="https://fonts.googleapis.com/css?family=Roboto:300,400,500,700&display=swap" rel="stylesheet">

    <link rel="stylesheet" type="text/css" href="/Content/css/styles.min.css?v=320225" />

    <link rel="stylesheet" type="text/css" href="/Content/css/mobile_nav.css?v=320225" />
    <link rel="stylesheet" type="text/css" href="/Content/css/overwrite.css?v=320225" />
    <link rel="stylesheet" type="text/css" href="/Content/css/flexslider.css" />
    <link rel="stylesheet" type="text/css" href="/Content/css/slides.css?v=320225" />

    <!--[if IE 7]>
        <link rel="stylesheet" type="text/css" href="/Content/css/allstyles.min.css?v=320225"/>
        <link rel="stylesheet" type="text/css" href="/Content/css/ie-styles.min.css?v=320225"/>
    <![endif]-->
    <!--[if IE 8]>
        <link rel="stylesheet" type="text/css" href="/Content/css/allstyles.min.css?v=320225"/>
    <![endif]-->

        <link rel="canonical" href="https://www.globenewswire.com/news-release/2020/03/18/2002578/0/en/Beyond-Air-Accelerates-LungFit-BRO-COVID-19-Program.html" />
    <script src="/Scripts/jquery-1.7.2.min.js" type="text/javascript"></script>
    <script src="/Scripts/jquery.validate.min.js" type="text/javascript"></script>
    <script src="/Scripts/jquery-ui-1.8.18.min.js" type="text/javascript"></script>
    <script src="/Scripts/datepicker-fr-CA.min.js" type="text/javascript"></script>
    <script src="/Scripts/jquery.unobtrusive-ajax.min.js" type="text/javascript"></script>
    <script src="/Scripts/myscripts.min.js?v=320225" type="text/javascript"></script>

    <!--<script src="/Scripts/user-culture-helper.js?v=320225" type="text/javascript"> </script>-->

    <script src="/Scripts/jquery.flexslider.js" type="text/javascript"></script>

    <!-- Jeditable settings: see http://www.appelsiini.net/projects/jeditable for more info and options -->
    <script src="/Scripts/jquery.jeditable.js" type="text/javascript"></script>

    
    <script type="text/javascript">
        var detailResource = {
            FromEmailRequired: 'From email address in required.',
            InValidEmailAddress: 'Please enter a valid email address,',
            ContactEmailBodyRequired: 'Description is required.',
            EmailSendSuccessfully: 'Email sent sucessfully!',
            CAPTCHAFlagNotSet: 'CAPTCHA flag not set',
            ResponseNull: 'Response is null'
        }
    </script>

    <script src="/Scripts/News/details.js" type="text/javascript"></script>

    <!-- Need all 3 for mediaplayer -->
    <script src="/Scripts/MediaPlayer/includes/steal.js" type="text/javascript"></script>
    <script src="/Scripts/MediaPlayer/includes/production.js" type="text/javascript"></script>
    <script src="/Scripts/MediaPlayer/mediaplayer.js" type="text/javascript"></script>

    <script type="text/javascript">
        $(document).ready(function () {
            $(function () {
                if ($.trim($('#article_image-box').html()) == '') {
                    $('#article_image-box').hide();
                }
            });

            // Wraps large tables with a scroll bar
            // Measures table width and applies container if width > than container width
            function sliderTable() {
                var contentWidth = $('#content-L2').width();
                $('#content-L2 table').each(function () {
                    var tableWidth = $(this).outerWidth();
                    var container = $(this).parent();
                    if (tableWidth > contentWidth) {
                        if (!container.hasClass("table-wrap")) { // Make sure there is no wrapper to avoid infinite wrappers on resize
                            $(this).wrap('<div class="table-wrap"></div>'); // Creates wrapper
                        }
                    } else {
                        if (container.hasClass("table-wrap")) { // Make sure there is a wrapper to avoid unnecessary DOM rewriting
                            $(this).unwrap(); // removes wrapper
                        }
                    }
                });
            };
            /*function sliderTable() {
                $('#content-L2 table').each(function () {
                    $(this).wrap('<div class="table-wrap"></div>');
                });
            };*/

            function removeContentR2() {

                if (($.trim($('#info-7').html()) == '') && ($.trim($('#info-8').html()) == '') && ($.trim($('#info-9').html()) == '') && ($.trim($('#info-1').html()) == '')) {
                    $('#content-R2').hide();
                    $('#content-L2').width('98%');
                    $('#share-print').width('98%');
                    $('#post-content-metadata').width('98%');
                    $('.articleinfo-box').css({ "width": "98%" });
                    $('#relatedarticles').width('98%');
                    $('.table-wrap').css({ "max-width": "98%" });
                }
            }

            sliderTable(); // initial call

            $(window).resize(function () { // functions that run on resize can be placed in this container
                sliderTable(); // call on resize
            });

            removeContentR2();
        });
    </script>

        <script type="text/javascript">
            var userActivityUrl = 'https://www.globenewswire.com/SocialMediaActivity/Log';
            var articleId = '2002578';
        </script>

    <script type="text/javascript">
        var addthis_config = {
            pubid: "ra-55ed2d186bf85af1",
            services_exclude: "twitter,linkedin,pinterest_share,facebook"
        }


    </script>


    <script type="text/javascript" src="https://apis.google.com/js/plusone.js"></script>


    

    <link rel="stylesheet" type="text/css" href="/styles/gnw_nitf.css?v=320225" />

    <script type="text/javascript">var switchTo5x = false</script>
    <!-- ShareThis Scripts-->
        <!-- AddThis Scripts-->
            <script type="text/javascript" src="https://s7.addthis.com/js/300/addthis_widget.js"></script>
            <script type="text/javascript" src="https://apis.google.com/js/plusone.js"></script>
        <script type="text/javascript">
            addthis.addEventListener('addthis.menu.share', LogUserAddThisActivity);
        </script>

    <script type=\"application/ld+json\">
        {"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","id":"https://www.globenewswire.com/news-release/2020/03/18/2002578/0/en/Beyond-Air-Accelerates-LungFit-BRO-COVID-19-Program.html"},"Headline":"Beyond Air Accelerates LungFit™ BRO COVID-19 Program","DatePublished":"3/18/2020","DateModified":"3/18/2020","inLanguage":"en","author":{"@type":"Person","name":"Beyond Air™"},"publisher":{"@type":"Organization","name":"GlobeNewswire","logo":{"@type":"ImageObject","url":"https://www.globenewswire.com/Content/Images/intrado.png"}},"sourceOrganization":{"@type":"Organization","name":"Beyond Air™","logo":{"@type":"ImageObject","url":"http://www.globenewswire.com/Attachment/LogoDisplay/811484?filename=811484.png&size=1"}},"Description":"Prepared to test LungFit™ BRO in COVID-19 patients in a clinical study starting in April pending FDA approval of recently submitted IDE (investigational device exemption)"}
    </script>


    
    <!-- Search Engine Friendly Metadata  -->
    <meta name="author" content="Beyond Air™" />
    <meta name="keywords" content="Nasdaq:XAIR, Beyond Air™" />
    <meta name="description" content="Prepared to test LungFit™ BRO in COVID-19 patients in a clinical study starting in April pending FDA approval of recently submitted IDE (investigational device exemption)" />
    <meta name="title" content="Beyond Air Accelerates LungFit™ BRO COVID-19 Program" />
    <meta name="ticker" content="Nasdaq:XAIR" />
    <meta name="DC.date.issued" content="3/18/2020" />
    <!-- Google site verification meta tag -->
    <meta name="google-site-verification" content="TPh-fYpDjXZUz98ciWasVb52qbvctqomC6zZc8vuUPU" />
    <!-- Google Syndication source  -->
    <link name="syndication-source" href="http://www.globenewswire.com/news-release/2020/03/18/2002578/0/en/Beyond-Air-Accelerates-LungFit-BRO-COVID-19-Program.html" />
    <meta name="original-source" content="http://www.globenewswire.com/news-release/2020/03/18/2002578/0/en/Beyond-Air-Accelerates-LungFit-BRO-COVID-19-Program.html" />
    <!-- Twitter Cards -->
    <meta name="twitter:card" content="summary" />
    <meta name="twitter:site" content="@globenewswire" />
    <meta name="twitter:title" content="Beyond Air Accelerates LungFit™ BRO COVID-19 Program" />
    <meta name="twitter:description" content="Prepared to test LungFit™ BRO in COVID-19 patients in a clinical study starting in April pending FDA approval of recently submitted IDE (investigational device exemption)" />
    <!-- <meta name="twitter:creator" content="??????" />  -->
    <!-- Open Graph-->
    <meta property="og:title" content="Beyond Air Accelerates LungFit™ BRO COVID-19 Program" />
    <meta property="og:type" content="article" />

    <meta name="twitter:image" content="http://www.globenewswire.com/Attachment/LogoDisplay/811484?filename=811484.png&size=1" />
    <meta property="og:image" content="http://www.globenewswire.com/Attachment/LogoDisplay/811484?filename=811484.png&size=1" />
<meta property="og:url" content="http://www.globenewswire.com/news-release/2020/03/18/2002578/0/en/Beyond-Air-Accelerates-LungFit-BRO-COVID-19-Program.html" />
<meta property="og:description" content="Prepared to test LungFit™ BRO in COVID-19 patients in a clinical study starting in April pending FDA approval of recently submitted IDE (investigational device exemption)" />
<meta property="og:article:published_time" content="3/18/2020 12:30:00 PM" />
<meta property="og:article:author " content="Beyond Air™" />
<meta property="og:article:tag" content="Beyond Air™, " />
<meta property="og:locale" content="en_US" />
<meta property="og:site_name" content="GlobeNewswire News Room" />

        <script type="text/javascript">

            var _gaq = _gaq || [];
            _gaq.push(['_setAccount', 'UA-24489796-1']);
            _gaq.push(['_setDomainName', '.globenewswire.com']);
            _gaq.push(['_trackPageview']);

            (function() {
                var ga = document.createElement('script');
                ga.type = 'text/javascript';
                ga.async = true;
                ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
                var s = document.getElementsByTagName('script')[0];
                s.parentNode.insertBefore(ga, s);
            })();
        </script>
    <script>

        window.refreshAntiforgeryTokens = function() {

            var allTokens = $("input[name='__RequestVerificationToken']");

            if (allTokens && allTokens.length > 0) {

                $.each(allTokens, function (i, contextElement) {

                    try {

                        $.ajax({
                            type: 'GET',
                            url: '/Token/RefreshAntiForgeryToken',
                            contentType: "application/json; charset=utf-8",
                            dataType: "html",
                            cache: false,
                            async: false,
                            success: function (response) {
                                var newToken = $('<div />').html(response).find('input[type="hidden"]').val();
                                $(contextElement).val(newToken);
                                console.log('done');
                            },
                            error: function (ssoToken) {
                                console.error('Error RefreshAntiForgeryToken, unable to get new token' + ssoToken);
                            }
                        });

                    } catch (e) {

                    }
                });
            }
        }

        $(document).ready(function () {

            var common = {};

            common.addActive = function(selector, activeClass) {
                $(selector).addClass(activeClass);
            };
            common.removeActive = function(selector, activeClass) {
                $(selector).removeClass(activeClass);
            };
            common.checkAndChangeActiveState = function(current, container, selector, activeClass) {
                if (current.parents(container).hasClass(activeClass)) {
                    common.removeActive(selector, activeClass);
                } else {
                    common.addActive(selector, activeClass);
                }
            };

            $("form").submit(function () {
                var bSubmit = true;
                $("form :input[type=text], textarea").each(function (i, v) {
                    var element = $(v);
                    var value = element.val();
                    /*
                    <	  	    #start with opening tag "<"
                     (		    #   start of group #1
                       "[^"]*"	#	allow string with double quotes enclosed - "string"
                       |		#	..or
                       '[^']*'	#	allow string with single quote enclosed - 'string'
                       |		#	..or
                       [^'">]	#	cant contains one single quotes, double quotes and ">"
                     )		    #   end of group #1
                     *		    # 0 or more
                    >		    #end with closing tag ">"
                    */
                    var re = new RegExp("<(\"[^\"]*\"|'[^']*'|[^'\">])*>", "g");
                    var myArray = value.match(re);
                    if (myArray != null) {
                        alert("Invalid characters. Remove < > and try again.");
                        bSubmit = false;
                    }
                });
                if (!bSubmit) return false;
            });

            // Responsive Menu

            $('a.hamburger').click(function() {
                var current = $(this);
                var container = ".resp-header";
                var selector = ".invis-backdrop, .resp-header, #header";
                var activeClass = "active";
                common.checkAndChangeActiveState(current, container, selector, activeClass);
            });
            $('.invis-backdrop').click(function() {
                var selector = ".invis-backdrop, .resp-header, #header";
                var activeClass = "active";
                common.removeActive(selector, activeClass);
            });
            // END Responsive Menu

            // Show / Hide Quick Search
            $('.qsearch-link').click(function() {
                var current = $(this);
                var container = ".qsearch-container";
                var selector = container;
                var activeClass = "active";
                common.checkAndChangeActiveState(current, container, selector, activeClass);
            });
            // END Show / Hide Quick Search

        });
        $(function () {
            $('#quicksearch-textbox').autocomplete({
                source: '/Search/AutoOrg',
                select: function (event, ui) {
                    this.value = ui.item.label;
                    return false;
                }
            });
        });
    </script>
</head>
<body>
<!--The header goes here-->
<div class="invis-backdrop"> <!-- .invis-backdrop used in jquery -->
    <!-- Please leave this empty. This is used to create a click state -->
</div>
<div class="resp-header"> <!-- .resp-header used in jquery -->
    <div class="resp-header-inner">
        <a class="hamburger">
            <i class="fas fa-bars"></i>
            <i class="fas fa-times"></i>
        </a>
        <a href="/Index" class="gnw-headline">GlobeNewswire</a>
    </div>
</div>
<div id="header"> <!-- #header used in jquery -->
    <div class="header-nav">
        <div id="logodiv">
            <a href="https://www.globenewswire.com/en" title="Home" id="logolink">
                <img src="/Content/Images/intrado.png" alt="Intrado Logo"/>
            </a>
        </div>


        <!-- QUICKSEARCH:
        See this website for more info about server-side search setup. 
        http://jqueryui.com/demos/autocomplete/
        Look at the examples on the left, then look at the source offered on the page.
        -->
        <div class="qsearch-container">
            <a class="qsearch-link">
                <i class="fas fa-search"></i>
            </a>
            <div id="quicksearch" class="clearfix">
                <form action="/Search" method="POST" id="layout_search_form">
                    <input name="__RequestVerificationToken" type="hidden" value="Nu28sG6vpXb28DEm3dmm0w6OHx1pnQBJmF85pA7MdcvCi/26WT0ufVkFwr/1LQLbX36A642SSA4HHAZNcB63kjjhEixRKMlfiXACAe3dUIfw4ITbjvcJD6ZlaqspyhVp8s6R2Q==" />
                    
                    <input id="quicksearch-textbox" name="quicksearch-textbox" onfocus="if(this.value ==&#39;Search&#39;) { this.value = &#39;&#39;; }" type="text" value="Search" />

                    <a href="#" id="quicksearch-button" title="Search" onclick="$('#layout_search_form').submit();return false;">
                        <i class="fas fa-search"></i>
                    </a>
                </form>
            </div>
        </div>
        <!-- End quicksearch -->


<!-- SIGN IN / REGISTER: -->
    <div id="loginContainer">
        <a href="/Home/Registration" ><span id="register-button">Register</span></a>
        <a href="/Home/Signin" ><span id="signin-button">Sign In</span></a>
    </div>
<!-- End sign in/ register -->

        <!-- Language selection-->
        <div id="contact-top-pc-browser">
            <a id="english-culture" class="selected-culture" href="/news-release/2020/03/18/2002578/0/en/Beyond-Air-Accelerates-LungFit-BRO-COVID-19-Program.html" data-href="/news-release/2020/03/18/2002578/0/en/Beyond-Air-Accelerates-LungFit-BRO-COVID-19-Program.html"><span>English</span></a>
            <a id="french-culture" class="selected-culture" href="/fr/news-release/2020/03/18/2002578/0/en/Beyond-Air-Accelerates-LungFit-BRO-COVID-19-Program.html" data-href="/fr/news-release/2020/03/18/2002578/0/en/Beyond-Air-Accelerates-LungFit-BRO-COVID-19-Program.html"><span>Fran&ccedil;ais</span></a>   
        </div>
        <!-- End Language selection-->
        <!-- top-link-container -->
        <div class="top-link-container">
            <a href="https://meet.westuc.com/globenewswire-contact-us"><span>Contact Us</span></a>
            <a href="https://w.globenewswire.com/en/publishing/distribution"><span>Global Distribution</span></a>
            <a href="https://w.globenewswire.com/en/publishing/newswire"><span>Newswire Services</span></a>
            <a href="https://w.globenewswire.com/en/publishing/filing"><span>Regulatory Filings</span></a>
            <a href="https://w.globenewswire.com/en/publishing/partners"><span>Media Partners</span></a> 
        </div>
    </div>
</div>
    <!--End header-->

    <!-- Start Body -->
    





<div id="container-article" itemscope itemtype="http://schema.org/NewsArticle">
    <meta itemprop="wordCount" content="0" />
    <meta itemprop="inLanguage" content="en" />
    <meta itemprop="description" name="description" content="Prepared to test LungFit™ BRO in COVID-19 patients in a clinical study starting in April pending FDA approval of recently submitted IDE (investigational device exemption)" />
    <meta itemprop="dateModified" content="3/18/2020" />

    <meta itemscope itemprop="mainEntityOfPage" itemType="https://schema.org/WebPage" itemid="http://www.globenewswire.com/news-release/2020/03/18/2002578/0/en/Beyond-Air-Accelerates-LungFit-BRO-COVID-19-Program.html" />

    <div class="logo-area">
                <span><img alt="Beyond-Air-The-Magic-of-Breathing.png" itemprop="image" src="/news-release/logo/811484/0/811484.png?lastModified=03%2F18%2F2020%2008%3A30%3A18&amp;size=2&amp;v=2002578" /></span>

    </div>

    <br />
    <h1 class="article-headline" itemprop="headline">Beyond Air Accelerates LungFit™ BRO COVID-19 Program</h1>
    <h2 class="subheadline" itemprop="alternativeHeadline"><span>Prepared to test LungFit™ BRO in COVID-19 patients in a clinical study starting in April pending FDA approval of recently submitted IDE (investigational device exemption)</span></h2>

    <!--Begin content, LEFT SIDE-->
    <div id="content-L2">
            <div class="share-bar">
                <a style="float: left; margin-top: 2px; margin-left: 5px" class="addthis_button_facebook facebook">
                    <i class="fab fa-facebook-f"></i>
                </a>
                <a style="float: left; margin-top: 2px; margin-left: 5px" class="addthis_button_twitter twitter">
                    <i class="fab fa-twitter"></i>
                </a>
                <a style="float: left; margin-top: 2px; margin-left: 5px" class="addthis_button_linkedin linkedin">
                    <i class="fab fa-linkedin-in"></i>
                </a>
                <a style="float: left; margin-top: 2px; margin-left: 5px" class="gplus" href="https://plus.google.com/share?url=http://www.globenewswire.com/news-release/2020/03/18/2002578/0/en/Beyond-Air-Accelerates-LungFit-BRO-COVID-19-Program.html" onclick="javascript:window.open(this.href,
    '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=600,width=600');return false;">
                    <i class="fab fa-google-plus-g"></i>
                </a>
                <a style="float: left; margin-top: 2px; margin-left: 5px" class="addthis_button_pinterest pinterest">
                    <i class="fab fa-pinterest"></i>
                </a>
                <a style="margin-top: 2px; margin-left: 5px" class="with-text addthis_button_email">
                    <i class="fas fa-at"></i><span>Email</span>
                </a>
                <a href="/news-release/2020/03/18/2002578/0/en/Beyond-Air-Accelerates-LungFit-BRO-COVID-19-Program.html?print=1" title="Print" class="with-text">
                    <i class="fas fa-print"></i><span>Print Friendly</span>
                </a>
                <a class="with-text addthis_button_compact"><i class="fas fa-share-alt"></i><span>Share</span></a>
            </div>

            <div id="post-content-metadata" class="clearfix">
                <span class="post-metadata dt-green">
                    <span itemprop="datePublished">
                        <em><time datetime="2020-03-18T12:30:00Z">March 18, 2020 08:30 ET</time> </em>
                    </span>
                </span> | <strong>Source:</strong>  <span itemprop="author copyrightHolder">Beyond Air™</span>
                <div class="spacer"></div>
                <div class="post-type  rightalign"></div>
            </div>

        <!--Begin text with pre tag-->



        <!--Begin text without pre-->
            <span class="article-body" itemprop="articleBody"><p align="justify">GARDEN CITY, N.Y., and REHOVOT, Israel, March  18, 2020  (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions, serious lung infections<u>,</u>   including those suffering from COVID-19, and pulmonary hypertension, as well as gaseous NO for the treatment of solid tumors, today announced that the Company has drawn $5 million from its previously announced $25 million line of credit to provide the resources to more rapidly move the <em>LungFit</em><em>™</em><em> BRO</em> COVID-19 program forward. <br /></p>      <p align="justify">“While we await feedback from BARDA (a division of HHS) and other US and international agencies, this money allows us to accelerate the anticipated COVID-19 clinical study start,” said Steve Lisi, Chairman and Chief Executive Officer of Beyond Air. “While we anticipate receiving grants on an emergency basis, we have decided that there is an urgent need to commence the study as soon as possible pending IDE approval from FDA.”</p>      <p><strong>About Beyond Air, Inc.</strong></p>      <p align="justify">Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System, LungFit™, that uses NO generated from ambient air to deliver precise amounts of NO to the lungs for the potential treatment of a variety of pulmonary diseases. The LungFit™ can generate up to 400 ppm of NO for delivery either continuously or for a fixed amount of time and has the ability to either titrate dose on demand or maintain a constant dose.  The Company is currently applying its therapeutic expertise to develop treatments for pulmonary hypertension in various settings, in addition to treatments for lower respiratory tract infections that are not effectively addressed with current standards of care. Beyond Air is currently advancing its revolutionary LungFit™ in clinical trials for the treatment of bronchiolitis and severe lung infections such as nontuberculous mycobacteria (NTM), as well as for the potential treatment of COVID-19 patients.  Additionally, Beyond Air is using ultra-high concentrations of NO with a proprietary delivery system to target certain solid tumors in the pre-clinical setting.  For more information, visit <a href="https://www.globenewswire.com/Tracker?data=IMZ9jkrG07GF3oM1HEMmqgCbtIWn5wneyb0TwiseM8b-GlhIxOYsXRUsjqIQrtfvszwOlejrrTh8bIxHZS9NJg==" rel="nofollow" target="_blank" title=""><u>www.beyondair.net</u></a>.</p>      <p><strong>About Nitric Oxide (NO)</strong></p>      <p align="justify">Nitric Oxide (NO) is a powerful molecule proven to play a critical role in a broad array of biological functions. In the airways, NO targets the vascular smooth muscle cells that surround the small resistance arteries in the lungs and is used in adult respiratory distress syndrome and persistent pulmonary hypertension of the newborn.  Additionally, NO is believed to play a key role in the innate immune system and in vitro studies suggest that NO possesses anti-microbial activity not only against common bacteria, including both gram-positive and gram-negative, but also against other diverse organisms, including mycobacteria, viruses, fungi, yeast and parasites, and has the potential to eliminate multi-drug resistant strains. </p>      <p><strong>About the LungFit™ NO Generator and Delivery System*</strong></p>      <p align="justify">Beyond Air’s NO Generator and Delivery System is a cylinder-free, phasic flow Nitric Oxide delivery system and has been designated as a medical device by the US Food and Drug Administration (FDA). The ventilator compatible version of the device can generate NO from ambient air on demand for delivery to the lungs at concentrations ranging from 1 part per million (ppm) to 80 ppm. The LungFit™ could potentially replace large, high-pressure NO cylinders providing significant advantages in the hospital setting, including greatly reducing inventory and storage requirements, improving overall safety with the elimination of NO<sub>2</sub> purging steps, and other benefits. The LungFit™ can also deliver NO at concentrations above 80 ppm for which intended treatments are: bronchiolitis in the hospital setting, and chronic, refractory lung infections in the home setting.  For the first time, Beyond Air intends to offer NO treatment in the home setting with the elimination of cylinders.</p>      <p align="justify">* Beyond Air’s LungFit™ is not approved for commercial use and Beyond Air is not suggesting use over 80 ppm or use at home.  Beyond Air’s LungFit™ is for investigational purposes only. </p>      <p align="justify"><strong>About COVID-19</strong><br />COVID-19 (coronavirus disease 2019) is an <a href="https://www.globenewswire.com/Tracker?data=IVPilIKyOc0F_sw4R1CQ4GjTyGTgVlBmI3mA6gumubQzymHjuZZefYAorkcsqptK-TJAOrxI3V12ptWQNs53lyMCsQsqNW2eiycQRxTB4zL4HVv3XqeXD8CfmePaB0-t" rel="nofollow" target="_blank" title="infectious disease">infectious disease</a> caused by the severe acute respiratory syndrome <a href="https://www.globenewswire.com/Tracker?data=ZnvFiheQNhttg3JtUgem7IbcXjeMMEK0IhmsqSZ5wKcf1Qo7MCyvEwlPcEVNACkXGv7sdFqCdYvVfPyigcZS6IBsNOHySP-UF2wDAEqoE7niM0zgx8FrXb7_MBjsMMayNZlOpVazJ1ibJVLc0VJzylVQ4kvaT6K7tcvpEvLNM5I=" rel="nofollow" target="_blank" title="coronavirus 2">coronavirus 2</a> (SARS-CoV-2). COVID-19 first emerged in <a href="https://www.globenewswire.com/Tracker?data=FFGsVKJ4lzwxN0pnPA795USFr48mHUxITrTOwwzuopfmVMvV32rhjl8g-Qy8S3vL9PG_4R8cX0pV1jIbpXcKXQ==" rel="nofollow" target="_blank" title="Wuhan">Wuhan</a>, <a href="https://www.globenewswire.com/Tracker?data=d6i5sbz1sKDkcnZmyjMSHootT91pW4rnDdaWeDuGXDQCt3x-oMhr3d0TNLNtukrj_uezl1ERelRoZcyzP3NEvA==" rel="nofollow" target="_blank" title="China">China</a> in December of  2019. Those affected develop <a href="https://www.globenewswire.com/Tracker?data=mM6NNY2gle245OLObQnELqsNFss17WSCV35r5oJjNgElp-8X3oGlY-m5opiAferl1cE9BDAX-TeAvAqfHwurLg==" rel="nofollow" target="_blank" title="fever">fever</a>, cough, shortness of breath and/or difficulty breathing. While the majority of cases result in mild symptoms, some can progress to <a href="https://www.globenewswire.com/Tracker?data=F_5pZKVJm7EqfQXzIDYp8n6Z2hnJzmn5OcNVwI9auJYsYcj9E6_qYUYkL065GrOZf5pp1mHqwGu0vWE-P7IU696ziA2c16qLiq7B8_0d_A4=" rel="nofollow" target="_blank" title="pneumonia">pneumonia</a> and <a href="https://www.globenewswire.com/Tracker?data=AFBgjMsmuL-B6rxsYbG-9HXNfvG-tGS2BogvoeNhtoVJPO2M83woIdrmoacJLWbOqKUcy2IYEbOp_Ggg_K0DmKXWlnXUjD6Q3Mit4ATPvo4ZtBNsCXKjptGMKUM_LV0Q" rel="nofollow" target="_blank" title="multi-organ failure">multi-organ failure</a>. The<a href="https://www.globenewswire.com/Tracker?data=gZnk2P9iAt8lLDId9gAVvY7aXMx_5Xz0tMZnDblbCTMkyPoPsNTK_e7G18KsMdsLHb5Ume50ZECOx3v4YI8nAU4C401aXy9S8kaFe_N11sLZMJfDJbnLLGe3If4c0w5p" rel="nofollow" target="_blank" title="fatality rate"> fatality rate</a> is currently estimated at between 1% and 3%. Older adults and people who have serious chronic medical conditions are at an increased risk of developing severe complications from COVID-19. There is no specific treatment approved for COVID-19 and patients are managed with <a href="https://www.globenewswire.com/Tracker?data=IMd1skSCy4MOJkF_DQiQB7sWp5CbCc8MQha1HPNRVZINJlLtXjeZrjz2v_FqnK4C2R7Z-ySlWtzsQ_meTIR489DUYu2PV1Io0wQr3Xpetz0aTa0nbrG_-E9EShbQ4kpf" rel="nofollow" target="_blank" title="supportive care">supportive care</a>. NO may prove to be a treatment as the impact on the lung should result in bronchodilation, reduction in inflammation and inhibition of the viral replication process. As of March 17, 2020, more than 190,000 cases of COVID-19 and more than 7,500 deaths have been reported in more than 160 countries.</p>      <p><strong>About Bronchiolitis</strong></p>      <p align="justify">The majority of hospital admissions of infants with bronchiolitis are caused by respiratory syncytial virus (RSV). RSV is a common and highly transmissible virus that infects the respiratory tract of most children before their second birthday.  While most infants with RSV present with minor respiratory symptoms, a small percentage develop serious lower airway infections, termed bronchiolitis, which can become life-threatening. The absence of treatment options for bronchiolitis limits the care of these sick infants to largely supportive measures. Beyond Air’s system is designed to effectively deliver over 80 ppm NO, for which preliminary studies indicate may eliminate bacteria, viruses, fungi and other microbes from the lungs.</p>      <p align="justify"><strong>Forward-Looking Statement</strong><br />This press release contains “forward-looking statements” concerning inhaled nitric-oxide and the Company’s LungFit™ product, including statements with regard to potential regulatory developments, the potential impact on patients and anticipated benefits associated with its use. Forward-looking statements include statements about our expectations, beliefs, or intentions regarding our product offerings, business, financial condition, results of operations, strategies or prospects. You can identify such forward-looking statements by the words “anticipates,” “expects,” “intends,” “impacts,” “plans,” “projects,” “believes,” “estimates,” “likely,” “goal,” “assumes,” “targets” and similar expressions and/or the use of future tense or conditional constructions (such as “will,” “may,” “could,” “should” and the like) and by the fact that these statements do not relate strictly to historical or current matters. Rather, forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause our actual results to differ materially from any future results expressed or implied by the forward-looking statements. These forward-looking statements are only predictions and reflect our views as of the date they are made with respect to future events and financial performance. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements, including risks related to: our approach to discover and develop novel drugs, which is unproven and may never lead to efficacious or marketable products; our ability to fund and the results of further pre-clinical and clinical trials; obtaining, maintaining and protecting intellectual property utilized by our products; our ability to enforce our patents against infringers and to defend our patent portfolio against challenges from third parties; our ability to obtain additional funding to support our business activities; our dependence on third parties for development, manufacture, marketing, sales, and distribution of products; the successful development of our product candidates, all of which are in early stages of development; obtaining regulatory approval for products; competition from others using technology similar to ours and others developing products for similar uses; our dependence on collaborators;  our short operating history and other risks identified and described in more detail in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K and other filings with the SEC, all of which are available on our website. We undertake no obligation to update, and we do not have a policy of updating or revising, these forward-looking statements, except as required by applicable law.</p>      <p align="justify"><strong>CONTACT</strong><br />Steven Lisi, Chief Executive Officer<br />Beyond Air, Inc.<br /><a href="https://www.globenewswire.com/Tracker?data=03OEMstQnLzFxxnCMq3Js_49hmfvwbLOaJKV4hurROE5SJ_2EuyiLMlkK5MjMyM5T9zIoXizzC8zR6Rf4Ogsdr63sX7aYh99P0Jb1ogLyrY=" rel="nofollow" target="_blank" title=""><u>slisi@beyondair.net</u></a></p>      <p align="justify">Bob Yedid<br />LifeSci Advisors, LLC<br /><a href="https://www.globenewswire.com/Tracker?data=LAgEsv0BoSAwQ6z_6X39zrKL3RzutnU_ZmLnHYPseOk7fVBwuCIFoG-HBbsfqyH5QpdW4qTLak3Hw7bwbRuwfM06Rio3_QOJCHz7HsnpOK0=" rel="nofollow" target="_blank" title=""><u>Bob@LifeSciAdvisors.com</u></a> <br />(646) 597-6989</p>      <p> </p> </span>
        <!--Begin Related Articles-->
        <div id="relatedarticles">
            <div class="rel-articles"><h2>Related Articles</h2></div>
                    <h5>More articles issued by <i><a href="/Search?organization=Beyond%20Air%E2%84%A2">Beyond Air™</a></i></h5>

                <h5>More articles related to:</h5>

                <h5> <i><a href="/Search?sc=Company%20Announcement">Company Announcement</a></i> </h5>

        </div>
    </div>
    <!--Begin Content, RIGHT-->



<div id="content-R2">


           
<!-- Profile -->
    <div class="articleinfo-box" id="info-1">
        <div class="facet_header">Profile</div>
        <div itemprop="sourceOrganization" itemscope itemtype="http://schema.org/Organization">
            <p><span itemprop="name"><strong>Beyond Air™</strong></span></p>
                <meta itemprop="logo" url="http://www.globenewswire.com/Attachment/LogoDisplay/811484?filename=811484.png&size=1" alt="Company Name Logo"/>
        </div>
    </div>

<!-- Subscribe -->

<!-- RSS -->
<div class="articleinfo-box" id="info-3">
    <p><a href="/SubscribeToRss/Qel_bxfuZKFEug5n1H5y1Q%3d%3d"><img src="/Content/Images/rss-sub.png" class="valign-bott"/>&nbsp; Subscribe via RSS</a></p><br/>
    <p><a href="/SubscribeToAtom/Qel_bxfuZKFEug5n1H5y1Q%3d%3d"><img src="/Content/Images/rss-sub.png" class="valign-bott"/>&nbsp;Subscribe via ATOM</a></p><br/>
    <p><a href="/JSWidget/organization/Qel_bxfuZKFEug5n1H5y1Q%3d%3d"><img src="/Content/Images/rss-sub.png" class="valign-bott"/>&nbsp;Javascript</a></p>
</div>

<!-- Location -->
<div class="articleinfo-box" id="info-4">
            <p itemprop="dateline contentLocation"><img src="/Content/Images/icon-location.png" class="valign-bott">  Rehovot,  ISRAEL</p>
</div>
        <!-- Languages -->
    <!-- Contact -->
           <!-- Stock Quote-->
                <style>
                    .compname {
                        color: #999 !important;
                        font-family: SourceSansProRegular !important;
                        font-size: 18px !important;
                        font-weight: normal !important;
                    }
                </style>
                <div class="articleinfo-box" id="stock_quote">
                    <script>
                        var isFr = ('en' == 'fr');

                        function getFr(text) {

                            var en2Fr =
                            {
                                '>Last: <': '>Dern.<br> Cours: <',
                                '>Change: <': '>Var.: <br>&nbsp;<',
                                '>% Change: <': '>Var. %: <',
                                '>Open: <': '>Ouverture: <',
                                '>Previous Close: <': '>Cl&ocirc;ture veille: <',
                                '>Low: <': '>Bas: <br>&nbsp;<',
                                '>High: <': '>Haut: <br>&nbsp;<',

                                '>Market Cap: <': '>Valeur &agrave; la cote: <',
                                '>Shares Outs.: <': '>Actions en circ.: <',
                                '>EPS: <': '>BPA: <',
                                '>P/E Ratio: <': '>Ratio C/B: <',
                                '>Dividend: <': '>Dividende: <',
                                '>Yield: <': '>Rendement: <',
                                '>52 Week Low: <': '>Plancher (52 dern. sem.): <',
                                '>52 Week High: <': '>Plafond (52 dern. sem.): <',

                                '>Intraday<': '>Aujourd&apos;hui<',
                                '>3 Month<': '>3 mois<',
                                '>6 Month<': '>6 mois<',
                                '>1 Year<': '>1 an<',

                                '>Quote delayed at least 20 mins.<': '>Donn&eacute;es retard&eacute;es d&apos;au moins 20 minutes<'
                            };

                            text = text.replace(/(<td class=".+?">)(.+?)(<\/td>)/g,
                                function (_, p1, p2, p3) { return p1 + p2.replace(/\$(.+)/, "$1&nbsp;$").replace(".", ",") + p3 }
                            );
                            var keysArray = Object.keys(en2Fr);
                            for (var i = 0, len = keysArray.length; i < len; i++) {
                                var k = keysArray[i];
                                text = text.replace(k, en2Fr[k]);
                            }
                            return text;

                        }
                        $(function () {
                            $.ajax({
                                url: '//studio-5.financialcontent.com/ezir?Module=stockquote2&Ticker=XAIR',
                                type: 'GET'
                            }).success(function (html) {
                                if (html.indexOf("Symbol does not exist") > -1) {
                                    $("div#stock_quote").hide();
                                }
                                else {
                                    if (isFr) {
                                        html = getFr(html);
                                    }
                                    $("div#stock_quote").html(html);
                                }
                            });

                        }
                        );
                    </script>
                </div>
    <!-- Media Files -->

<!-- Media Files -->
<div class="articleinfo-box" id="info-7">
    <div class="facet_header">Media Files</div>


        <div class="article_small_img-container" id="articleimage_811484" suff="811484" >
            <img class="article_small_img" src="/news-release/logo/811484/0/811484.png?lastModified=03%2F18%2F2020%2008%3A30%3A18&amp;size=4" title="Logo  Download Options" alt="Beyond-Air-The-Magic-of-Breathing.png"/>
        </div>
        <div class="article_img_info">
            <p>
                <img src="/Content/Images/icon-downloadimage.gif" class="valign-bott pointer" id="articleimage-button_811484" 
                         title="Logo  Download Options"  suff="811484" loggerurl="/Attachment/LogImageView"/>
                <span id="articleimage-span_811484" suff="811484" class="valign-bott pointer">
                    <strong>Beyond-Air-The-Magic-of-Breathing.png</strong>
                </span>
            </p>
            <span>LOGO URL </span>| Copy the link below
            <input type="text" id="article_copy_811484" value="http://www.globenewswire.com/attachment-download-view/2002578/811484/4/1/0/811484.png" />
        </div>
        <div class="spacer"></div>
        <!-- The lightbox configuration -->
        <div id="attachment-modal_811484" title="Beyond-Air-The-Magic-of-Breathing.png">
            <img src="/news-release/logo/811484/0/811484.png?lastModified=03%2F18%2F2020%2008%3A30%3A18&amp;size=1" id="modal-img" alt="Beyond-Air-The-Magic-of-Breathing.png" />
            <p>Formats available:</p>
            <form id="attachment-modalform_811484" suff="811484">
                <input name="__RequestVerificationToken" type="hidden" value="+tQgjT9+6kFtblVBaWECdSKmHI6hDUiddhg8Up9ohYEpVGgdNLbfrNvJ0cNJnMAJkItB/zbwTsHUGqikA8l1kjVL815YbKM+ntog8ZY3deYDwUXbhQ/cU34tP8BzrS5yB4+xjw==" />
                <ul id="modal-filelist">

                    <li class="">
                        <label for="image-choice-1">
                            <input type="radio"  id="image-choice-1_811484" name="image-choice_811484" 
                                           value="/attachment-download-view/2002578/811484/4/1/0/811484.png"/>
                            Original
                        </label>
                    </li>

                    <li>
                        <label for="image-choice-2">
                            <input type="radio" id="image-choice-2_811484" name="image-choice_811484" 
                                       value="/attachment-download-view/2002578/811484/4/1/2/811484.png"/>
                            Medium
                        </label>
                    </li>
                    <li>
                        <label for="image-choice-3">
                            <input type="radio" id="image-choice-3_811484" name="image-choice_811484" 
                                       value="/attachment-download-view/2002578/811484/4/1/1/811484.png" checked="checked"/>
                            Small
                        </label>
                    </li>
                </ul>
                <input type="submit" class="register_submit submit-default" value="Download"/>
            </form>          
        </div>
        <!-- End of the lightbox configuration -->

</div>
    

    <!-- Related Links -->
</div>

    <!-- End Content R2 -->
    <div class="spacer"></div>
    
    <meta itemprop="provider" content="“GlobeNewswire”" />
    <meta itemprop="isFamilyFriendly" content="true" />
    <meta itemprop="copyrightYear" content="2020" />

</div>


<script>
    var googlePlusTracking = document.getElementsByClassName("gplus");
    console.log('add event listener');
    for (var i = 0; i < googlePlusTracking.length; i++) {
        googlePlusTracking[i].addEventListener('click', trackGooglePluse, false);
    }
</script>

    <!-- End Body -->

<div id="footer">
    <!--Left section of the footer goes here-->
    <div id="footer-L">
        <div class="footer-title"><h5>Newswire Distribution Network &amp; Management</h5></div>
        <!--Left half of left column
    <div class="footer-split-L1">
        <ul>

        </ul>
    </div>-->
        <!--Right half of left column
    <div class="footer-split-R1">-->
        <ul>
            <li><a href="/Index">Home</a></li>
            <li><a href="/NewsRoom">Newsroom</a></li>
            <li><a href="/Rss/List">RSS Feeds</a></li>
            <li><a href="/Home/about/Privacy">Legal</a></li>
        </ul>
        <!--</div>-->
    </div>
    <!--end left-->
    <!--Middle section of the footer goes here-->
    <div id="footer-R">
        <div class="footer-title"><h6>About Us</h6></div>
        <div class="footer-text"><strong>GlobeNewswire</strong> is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
    </div>
</div>

<!--end mid-->
<div class="spacer"></div>
<div id="copyright">&copy; 2020 GlobeNewswire, Inc. All Rights Reserved.</div>
</div>
    <!--End footer-->
    </body>
    </html>

